Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization

K18-hACE2 mice develop respiratory disease resembling severe COVID-19

(2021) Claude Kwe Yinda et al.   PLoS Pathogens

Dissecting strategies to tune the therapeutic potential of SARS-CoV-2–specific monoclonal antibody CR3022

(2021) Caroline Atyeo et al.   JCI Insight

Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses

(2021) Yongping Yang et al.   Vaccines

A new coronavirus associated with human respiratory disease in China

(2020) Fan Wu et al.   NATURE

A pneumonia outbreak associated with a new coronavirus of probable bat origin

(2020) Peng Zhou et al.   NATURE

Spatiotemporal regulation of type I interferon expression determines the antiviral polarization of CD4+ T cells

(2020) Marco De Giovanni et al.   NATURE IMMUNOLOGY

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2

(2020) Renhong Yan et al.   SCIENCE

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

(2020) Daniel Wrapp et al.   SCIENCE

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

(2020) Alexandra C. Walls et al.   CELL

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

(2020) Markus Hoffmann et al.   MOLECULAR CELL

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

(2020) Jun Lan et al.   NATURE

TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes

(2020) Ruochen Zang et al.   Science Immunology

A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

(2020) Lianpan Dai et al.   CELL

Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells

(2020) Yunlong Cao et al.   CELL

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

(2020) Xiangyang Chi et al.   SCIENCE

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

(2020) Lakshmanane Premkumar et al.   Science Immunology

TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells

(2020) Dorothea Bestle et al.   Life Science Alliance

ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis

(2020) Maryse Cloutier et al.   CYTOKINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge

(2020) Yfat Yahalom-Ronen et al.   Nature Communications

Cryo EM structure of the rabies virus ribonucleoprotein complex

(2019) Christiane Riedel et al.   Scientific Reports

Immunological Lessons from Respiratory Syncytial Virus Vaccine Development

(2019) Tracy J. Ruckwardt et al.   IMMUNITY

Ebola Vaccine Trials: Progress in Vaccine Safety and Immunogenicity

(2019) Keesha M. Matz et al.   Expert Review of Vaccines

Rhabdoviruses as vaccine platforms for infectious disease and cancer

(2018) Franz Zemp et al.   Biotechnology & Genetic Engineering Reviews

Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain

(2017) Anthony N. van den Pol et al.   JOURNAL OF VIROLOGY

G gene-deficient single-round rabies viruses for neuronal circuit analysis

(2016) Alexander Ghanem et al.   VIRUS RESEARCH

Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates

(2016) Qidi Wang et al.   ACS Infectious Diseases

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease

(2015) Patricio L. Acosta et al.   Clinical and Vaccine Immunology

Characterization of Monomeric Intermediates during VSV Glycoprotein Structural Transition

(2012) Aurélie A. Albertini et al.   PLoS Pathogens

The Measles Virus V Protein Binds to p65 (RelA) To Suppress NF- B Activity

(2011) K. M. Schuhmann et al.   JOURNAL OF VIROLOGY

Protein Transfer Into Human Cells by VSV-G-induced Nanovesicles

(2011) Philippe-Emmanuel Mangeot et al.   MOLECULAR THERAPY

Virus-like particles in vaccine development

(2010) António Roldão et al.   Expert Review of Vaccines

SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector

(2008) Sagar U. Kapadia et al.   VIROLOGY